Physician profile
Boris V Kovalenko
NPI 1366838278
$25,937.87
in general payments reported to CMS, 2019-2025
9 companies · $896 in 2025
The $896 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $7,645 · 2021: $12K · 2022: $1,368 · 2023: $4,009 · 2024: $496 · 2025: $896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,094 · Travel and Lodging: $2,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,093.76 |
| Travel and Lodging | $2,307.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $22,128.21 | 2020-2025 | Journey, Ri Hip Navigation, Or3o Dual Mobility |
| Zimmer Biomet Holdings, INC. | $2,057.90 | 2021-2025 | Persona, G7, Rosa |
| Stryker Corporation | $1,428.58 | 2021-2024 | Mako, Trident, T2 Alpha |
| Bioventus LLC | $106.19 | 2021-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $98.66 | 2021 | |
| Medical Device Business Services, INC. | $57.60 | 2021 | |
| Ferring Pharmaceuticals INC. | $31.01 | 2023-2024 | Euflexxa |
| Djo, LLC | $19.28 | 2024 | Cmf |
| Dynasplint Systems INC. | $10.44 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Kovalenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.